Annual report pursuant to Section 13 and 15(d)

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Condensed Consolidated Statements of Cash Flows (Details)

v3.22.4
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Condensed Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
2 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2021
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2022
Sep. 30, 2022
Nov. 08, 2021
Dec. 31, 2022
Dec. 31, 2020
Cash flows from operating activities:                    
Net income (loss) $ (682,149) $ (682,149) $ 106,227 $ 8,927 $ 36,963 $ 45,890 $ 152,117 $ 20,629 $ 91,758 $ 24,249
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:                    
Founders advisory fees - related party (change in accounting fair value) 0         (80,313) (154,026) 0 (117,302) 0
Depreciation and amortization expense 9,379         33,086 49,536 52,000 65,795 58,117
Interest and payment-in-kind on preferred shares 944         3,268 4,903 0 6,537 0
Share-based compensation 4,821       4,963 8,396 7,551 156 14,649 0
Deferred income taxes (2,155)       843 (129) (20,488) (11,244) (17,000) (2,684)
Amortization of deferred financing costs 224         793 1,196 14,592 1,602 3,471
Amortization of acquisition related inventory step-up 6,125       6,122 24,138 24,796 0 24,796 0
Gain on contingent earn-out 198   (3,644) (9,398)   (9,398) (13,042) 2,965 (12,706) 0
Unrealized loss (gain) on foreign currency 1,006   4,705 3,156   4,036 8,741 4,026 3,462 (5,640)
Loss on disposal of assets 0         9 9 0 9 0
Changes in operating assets and liabilities, net of acquisitions:                    
Accounts receivable 27,977         (44,477) (63,838) (28,872) (6,190) 11,734
Inventories (13,259)         (41,431) (40,759) (10,201) (61,934) 11,170
Income tax receivable         (5,968) (10,611)        
Prepaid expenses and other current assets (5,230)         7,301 9,058 (9,426) 1,922 (9,948)
Accounts payable 8,194         15,834 4,975 10,108 9,696 (9,608)
Deferred revenue 332         4,991 889 (149) (383) 0
Income taxes payable, net (8,985)           23,271 18,835 8,920 (5,860)
Accrued expenses and other current liabilities 436         2,789 15,547 146 (647) (5,572)
Founders advisory fees - related party (cash settled) 365,789         (53,547) (53,547) 0 (53,547) 0
Other liabilities 3,458         24 (73) 3,542 73 918
Net cash (used in) provided by operating activities 4,359         (89,351) (43,184) 67,991 (40,172) 70,826
Cash flows from investing activities:                    
Purchase of property and equipment (1,468)         (4,006) (6,024) (8,282) (8,613) (7,497)
Purchase price adjustment under Business Combination Agreement 0         (1,638) (1,638) 0 (1,638) 0
Net cash used in investing activities (1,210,623)         (5,644) (7,662) (15,746) (10,251) (9,467)
Cash flows from financing activities:                    
Ordinary shares repurchased 0         (5,008) (7,572) 0 (49,341) 0
Proceeds from exercise of warrants 0         529 529 0 529 0
Net cash used in financing activities (697,221)         (4,479) (7,043) (64,210) (48,812) (45,610)
Effect of foreign currency on cash and cash equivalents (738)         (578) (1,409) 435 431 (3,093)
Net change in cash and cash equivalents (1,904,223)         (100,052) (59,298) (11,530) (98,804) 12,656
Cash and cash equivalents, beginning of period 10,948 2,129,777 125,502   225,554 225,554 225,554 22,478 225,554 9,822
Cash and cash equivalents, end of period 225,554 225,554 166,256 125,502   125,502 166,256 10,948 126,750 22,478
Supplemental disclosures of cash flow information:                    
Cash paid for interest 174         17,919 18,299 24,559 35,488 45,441
Cash paid for income taxes 4,517         6,572 7,588 7,092 13,488 19,336
Non-cash investing and financing activities:                    
Liability portion of founders advisory fees - related party reclassified to additional paid in capital 0         13,783 13,783 $ 0 19,568 $ 0
As Reported                    
Cash flows from operating activities:                    
Net income (loss) (680,457)   78,711 7,223 37,811 45,034 123,745      
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:                    
Founders advisory fees - related party (change in accounting fair value)           (80,313) (154,026)      
Depreciation and amortization expense           33,086 49,536      
Interest and payment-in-kind on preferred shares           3,268 4,903      
Share-based compensation         5,724 12,465 19,297      
Deferred income taxes (670)       6,239 7,648 (72,441)      
Amortization of deferred financing costs           793 1,196      
Amortization of acquisition related inventory step-up 2,948       9,299 27,315 27,973      
Gain on contingent earn-out     (3,644) (9,398)   (9,398) (13,042)      
Unrealized loss (gain) on foreign currency     4,705 3,156   4,036 8,741      
Loss on disposal of assets           9 9      
Changes in operating assets and liabilities, net of acquisitions:                    
Accounts receivable           (44,477) (63,838)      
Inventories           (41,431) (40,759)      
Income tax receivable         (16,150) (24,778)        
Prepaid expenses and other current assets           7,301 9,058      
Accounts payable           15,834 4,975      
Deferred revenue           4,991 889      
Income taxes payable, net             88,673      
Accrued expenses and other current liabilities           2,789 15,547      
Founders advisory fees - related party (cash settled)           (53,547) (53,547)      
Other liabilities           24 (73)      
Net cash (used in) provided by operating activities           (89,351) (43,184)      
Cash flows from investing activities:                    
Purchase of property and equipment           (4,006) (6,024)      
Purchase price adjustment under Business Combination Agreement           (1,638) (1,638)      
Net cash used in investing activities           (5,644) (7,662)      
Cash flows from financing activities:                    
Ordinary shares repurchased           (5,008) (7,572)      
Proceeds from exercise of warrants           529 529      
Net cash used in financing activities           (4,479) (7,043)      
Effect of foreign currency on cash and cash equivalents           (578) (1,409)      
Net change in cash and cash equivalents           (100,052) (59,298)      
Cash and cash equivalents, beginning of period     125,502   225,554 225,554 225,554   225,554  
Cash and cash equivalents, end of period 225,554 225,554 166,256 125,502   125,502 166,256      
Supplemental disclosures of cash flow information:                    
Cash paid for interest           17,919 18,299      
Cash paid for income taxes           6,572 7,588      
Non-cash investing and financing activities:                    
Liability portion of founders advisory fees - related party reclassified to additional paid in capital           13,783 13,783      
Adjustment                    
Cash flows from operating activities:                    
Net income (loss) (1,692)   27,516 1,704 (848) 856 28,372      
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:                    
Founders advisory fees - related party (change in accounting fair value)           0 0      
Depreciation and amortization expense           0 0      
Interest and payment-in-kind on preferred shares           0 0      
Share-based compensation         (761) (4,069) (11,746)      
Deferred income taxes (1,485)       (5,396) (7,777) 51,953      
Amortization of deferred financing costs           0 0      
Amortization of acquisition related inventory step-up 3,177       (3,177) (3,177) (3,177)      
Gain on contingent earn-out     0 0   0 0      
Unrealized loss (gain) on foreign currency     0 0   0 0      
Loss on disposal of assets           0 0      
Changes in operating assets and liabilities, net of acquisitions:                    
Accounts receivable           0 0      
Inventories           0 0      
Income tax receivable         10,182 14,167        
Prepaid expenses and other current assets           0 0      
Accounts payable           0 0      
Deferred revenue           0 0      
Income taxes payable, net             (65,402)      
Accrued expenses and other current liabilities           0 0      
Founders advisory fees - related party (cash settled)           0 0      
Other liabilities           0 0      
Net cash (used in) provided by operating activities           0 0      
Cash flows from investing activities:                    
Purchase of property and equipment           0 0      
Purchase price adjustment under Business Combination Agreement           0 0      
Net cash used in investing activities           0 0      
Cash flows from financing activities:                    
Ordinary shares repurchased           0 0      
Proceeds from exercise of warrants                
Net cash used in financing activities           0 0      
Effect of foreign currency on cash and cash equivalents           0 0      
Net change in cash and cash equivalents           0 0      
Cash and cash equivalents, beginning of period     0   $ 0 0 0   $ 0  
Cash and cash equivalents, end of period $ 0 $ 0 $ 0 $ 0   0 0      
Supplemental disclosures of cash flow information:                    
Cash paid for interest           0 0      
Cash paid for income taxes           0 0      
Non-cash investing and financing activities:                    
Liability portion of founders advisory fees - related party reclassified to additional paid in capital           $ 0 $ 0